For the quarter ending 2025-09-30, RCKT has $368,033K in assets. $54,364K in debts. $75,948K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 75,948 | 32,819 | ||
| Investments | 146,810 | 238,675 | ||
| Prepaid expenses and other current assets | 4,922 | 5,661 | ||
| Total current assets | 227,680 | 277,155 | ||
| Property and equipment, gross | 57,213 | - | ||
| Less accumulated depreciation and amortization | 27,445 | - | ||
| Property and equipment, net | 29,768 | 32,524 | ||
| Goodwill | 39,154 | 39,154 | ||
| Intangible assets | 25,150 | 25,150 | ||
| Restricted cash | 1,365 | 1,365 | ||
| Deposits | 515 | 515 | ||
| Operating lease right-of-use assets, net | 3,653 | 3,830 | ||
| Finance lease right-of-use asset, net | 40,748 | 41,286 | ||
| Total assets | 368,033 | 420,979 | ||
| Accounts payable and accrued expenses | 28,258 | 40,505 | ||
| Operating lease liabilities, current | 1,015 | 1,010 | ||
| Finance lease liability, current | 1,897 | 1,884 | ||
| Total current liabilities | 31,170 | 43,399 | ||
| Operating lease liabilities, non-current | 2,758 | 2,928 | ||
| Finance lease liability, non-current | 19,375 | 19,380 | ||
| Preferred stock-Series BConvertible Preferred Shares | - | 0 | ||
| Other liabilities | 1,061 | 1,061 | ||
| Preferred stock-Series AConvertible Preferred Shares | - | 0 | ||
| Total liabilities | 54,364 | 66,768 | ||
| Common stock, 0.01 par value, 180,000,000 shares authorized 108,208,643 and 106,453,818 shares issued and outstanding as of september 30, 2025, and december 31, 2024, respectively | 1,082 | 1,079 | ||
| Additional paid-in capital | 1,711,297 | 1,701,608 | ||
| Accumulated other comprehensive (loss) income | -9 | -107 | ||
| Accumulated deficit | -1,398,701 | -1,348,369 | ||
| Total stockholders' equity | 313,669 | 354,211 | ||
| Total liabilities and stockholders' equity | 368,033 | 420,979 | ||
ROCKET PHARMACEUTICALS, INC. (RCKT)
ROCKET PHARMACEUTICALS, INC. (RCKT)